Supplementary Table S1.docx (20.8 kB)

Supplementary Table S1: Atogepant and sumatriptan: no clinically relevant drug-drug interactions in a randomized, open-label, crossover trial

dataset

posted on 2021-12-13, 15:57 authored by Ramesh Boinpally, Abhijeet Jakate, Matthew Butler, Antonia Periclou

Supplementary Table 1. Atogepant and Sumatriptan: No Clinically Relevant Drug-Drug Interactions in a Randomized, Open-label, Crossover Trial

Intervention Sequences

Funding

AbbVie

History

Usage metrics

Read the peer-reviewed publication

Atogepant and sumatriptan: no clinically relevant drug-drug interactions in a randomized, open-label, crossover trial

Pain Management

Categories

Keywords

Migraine prevention Oral CGRP receptor antagonist Atogepant Clinical trial Pharmacokinetics Drug-drug interactions Sumatriptan Clinical Pharmacology and Therapeutics Pharmacology and Pharmaceutical Sciences not elsewhere classified Medical and Health Sciences not elsewhere classified

Licence

CC BY-NC-ND 4.0

Exports